ZA817679B - Novel pharmaceutical preparations - Google Patents

Novel pharmaceutical preparations

Info

Publication number
ZA817679B
ZA817679B ZA817679A ZA817679A ZA817679B ZA 817679 B ZA817679 B ZA 817679B ZA 817679 A ZA817679 A ZA 817679A ZA 817679 A ZA817679 A ZA 817679A ZA 817679 B ZA817679 B ZA 817679B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical preparations
novel pharmaceutical
novel
preparations
pharmaceutical
Prior art date
Application number
ZA817679A
Other languages
English (en)
Inventor
Welf Von Daehne
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/207,614 external-priority patent/US4446144A/en
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of ZA817679B publication Critical patent/ZA817679B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0041Mammary glands, e.g. breasts, udder; Intramammary administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA817679A 1980-11-17 1981-11-06 Novel pharmaceutical preparations ZA817679B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/207,614 US4446144A (en) 1979-05-21 1980-11-17 Derivatives of penicillanic acid

Publications (1)

Publication Number Publication Date
ZA817679B true ZA817679B (en) 1982-10-27

Family

ID=22771286

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA817679A ZA817679B (en) 1980-11-17 1981-11-06 Novel pharmaceutical preparations

Country Status (8)

Country Link
AU (1) AU553440B2 (Direct)
DE (1) DE3145488A1 (Direct)
FR (1) FR2494115A1 (Direct)
GB (1) GB2087236B (Direct)
IE (1) IE51846B1 (Direct)
NL (1) NL8105212A (Direct)
NZ (1) NZ198878A (Direct)
ZA (1) ZA817679B (Direct)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8405611D0 (sv) * 1984-11-09 1984-11-09 Astra Laekemedel Ab Process for stabilization of bacampicillin hydrochloride
JPS6219592A (ja) * 1985-07-17 1987-01-28 Yoshitomi Pharmaceut Ind Ltd 安定なバカンピシリン・6β−ハロペニシラン酸塩の製造方法
WO2003063877A1 (en) * 2002-02-01 2003-08-07 Akzo Nobel N.V. Cefquinome composition for intra-mammary administration in cattle
AU2003269311A1 (en) * 2002-10-08 2004-05-04 Ancare New Zealand Ltd. Antibiotic formulation for intramammary administration in milking animals
NZ539478A (en) * 2002-10-25 2006-05-26 Akzo Nobel Nv Composition comprising cefquinome in a prolonged release vehicle of oil and aluminium distearate, which results in a prolonged duration in the blood plasma
US6911441B2 (en) 2002-12-16 2005-06-28 Akzo Nobel N.V. Prolonged release pharmaceutical composition
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004025324A1 (de) * 2004-05-19 2005-12-08 Boehringer Ingelheim Vetmedica Gmbh Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung
UY34913A (es) * 2012-07-17 2013-12-31 Bayer New Zealand Ltd Formaciones inyectables de antibiótico y sus métodos de aplicación
MY172561A (en) * 2012-07-17 2019-12-03 Bayer New Zealand Ltd Injectable antibiotic formulations and their methods of use
AU2013290827B2 (en) * 2012-07-17 2018-10-18 Elanco New Zealand Injectable antibiotic formulations and their methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180506A (en) * 1978-01-18 1979-12-25 Rex Pratt 6β-Bromo penicillanic acid
EP0013617B1 (en) * 1979-01-10 1984-07-04 Beecham Group Plc Penicillin derivatives, process for their preparation and pharmaceutical compositions containing certain of these compounds
US4397783A (en) * 1979-03-05 1983-08-09 Pfizer Inc. Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-β-congeners
IE49768B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives

Also Published As

Publication number Publication date
AU553440B2 (en) 1986-07-17
FR2494115A1 (fr) 1982-05-21
IE51846B1 (en) 1987-04-15
AU7739281A (en) 1982-05-27
NZ198878A (en) 1986-07-11
GB2087236B (en) 1984-08-01
NL8105212A (nl) 1982-06-16
FR2494115B1 (Direct) 1985-01-25
IE812572L (en) 1982-05-17
GB2087236A (en) 1982-05-26
DE3145488A1 (de) 1982-06-24

Similar Documents

Publication Publication Date Title
ZA814215B (en) Pharmaceutical preparations
ZW15983A1 (en) New pharmaceutical preparations
DE3273948D1 (en) Pharmaceutical preparations
DE3172028D1 (en) Pharmaceutical formulation
GB8313530D0 (en) Pharmaceutical preparations
ZA803567B (en) Pharmaceutical preparations
IL61721A0 (en) Nitroglycerin preparations
ZA793542B (en) Pharmaceutical preparations
ZA813465B (en) Pharmaceutical composition
GB8321595D0 (en) Pharmaceutical preparations
GB2080106B (en) Acyclovin preparations
ZA795039B (en) Pharmaceutical preparations
ZA796549B (en) New pharmaceutical preparations
GB2084019B (en) Anti-ischaemic pharmaceutical preparations
JPS56139420A (en) Drug
ZA817679B (en) Novel pharmaceutical preparations
GB2074028B (en) Pharmaceutical formulations
NZ197072A (en) Carbapenams and carbapen-2-ems and pharmaceutical preparations
ZA818221B (en) Pharmaceutical compounds
ZA811843B (en) Pharmaceutical preparations
ZA81650B (en) Pharmaceutical preparations
PH18457A (en) Pharmaceutical preparations
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
ZA817572B (en) Pharmaceutical formulation
ZA833506B (en) Pharmaceutical preparations